Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne Neumayr

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Pediatrics|July 3, 2003
Mycoplasma disease and acute chest syndrome in sickle cell diseaseLynne Neumayr, Evelyne Lennette, Dana Kelly, et al.
Transfusion|July 30, 2013
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)Elliott Vichinsky, Lynne Neumayr, Sean Trimble, et al.
Bone|April 24, 2008
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemiaEllen B Fung, Paul R Harmatz, Meredith Milet, et al.
American Journal of Hematology|August 14, 2012
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell diseaseAbdullah Kutlar, Kenneth Ataga, Marvin Reid, et al.
Journal of Pediatric Hematology/Oncology|January 25, 2003
Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell diseaseDeborah Dean, Lynne Neumayr, Dana M Kelly, et al.
British Journal of Haematology|February 1, 2011
The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trialWinfred Wang, Carlo Brugnara, Cathie Snyder, et al.
Blood Advances|August 12, 2018
Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)Ahmed A Daak, Carlton D Dampier, Beng Fuh, et al.
Blood|July 30, 2025
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLLJan A Burger, Paul M Barr, Tadeusz Robak, et al.
British Journal of Haematology|October 22, 2016
Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and strokeMichael M Dowling, Charles T Quinn, Claudio Ramaciotti, et al.
The Lancet. Neurology|June 17, 2019
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension studyThomas Klopstock, Fernando Tricta, Lynne Neumayr, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pediatrics|July 3, 2003
Mycoplasma disease and acute chest syndrome in sickle cell diseaseLynne Neumayr, Evelyne Lennette, Dana Kelly, et al.
Transfusion|July 30, 2013
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)Elliott Vichinsky, Lynne Neumayr, Sean Trimble, et al.
Bone|April 24, 2008
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemiaEllen B Fung, Paul R Harmatz, Meredith Milet, et al.
American Journal of Hematology|August 14, 2012
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell diseaseAbdullah Kutlar, Kenneth Ataga, Marvin Reid, et al.
Journal of Pediatric Hematology/Oncology|January 25, 2003
Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell diseaseDeborah Dean, Lynne Neumayr, Dana M Kelly, et al.
British Journal of Haematology|February 1, 2011
The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trialWinfred Wang, Carlo Brugnara, Cathie Snyder, et al.
Blood Advances|August 12, 2018
Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)Ahmed A Daak, Carlton D Dampier, Beng Fuh, et al.
Blood|July 30, 2025
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLLJan A Burger, Paul M Barr, Tadeusz Robak, et al.
British Journal of Haematology|October 22, 2016
Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and strokeMichael M Dowling, Charles T Quinn, Claudio Ramaciotti, et al.
The Lancet. Neurology|June 17, 2019
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension studyThomas Klopstock, Fernando Tricta, Lynne Neumayr, et al.
Pageof 3